Partnership of major national companies launches initiative, encourages President in pursuit of wider adoption of value-based models.
(screenshot from DRIVE Initiative webstie)
The United States easily outspends all other nations on healthcare without producing better results, and healthcare spending is growing at 5.6% a year: CMS projects that healthcare spending will represent 19.9% of the gross domestic product by 2025. Recognizing that such patterns may be unsustainable, and hoping to encourage a wider adoption of value-based care models, the Pacific Business Group on Health (PBGH) and the ERISA Industry Committee today announced the DRIVE Health Initiative to promote faster adoption of value-based care.
“It is absolutely critical for the health of Americans and our economy that value-based care is quickly embedded in the healthcare system,” David Lansky, president and CEO of PBGH, said in a statement. “Policy makers must focus on what works to achieve these goals, and we know that value-based care helps to drive down costs and improve patient outcomes.”
“DRIVE” stands for “Deliver Results, Innovation and Value for Everyone.” The initiative is backed by Fortune 500 companies such as Boeing, Target, and Chevron, as well as leading institutions like Stanford University. The DRIVE policy blueprint focuses on 3 elements:
The group sent a letter to President Donald J. Trump and HHS Secretary Tom Price, MD, calling for regulatory steps and market-based purchasing strategies, and submitted a policy proposal that the group said “will drive healthcare efficiency and effectiveness.”
According to the group’s statement, the historic reliance on fee-for-service payment is one culprit in the upward trajectory, as it is still used in “over 80% of healthcare transactions.”
Strategies like value-based payment, increased transparency, and greater consumer engagement have been shown to produce better quality care, the business groups say.
“The market based approach builds upon 20 years of innovation in payment, benefit design, and consumer engagement by the business community,” they say in the statement. “Value-based care ensures patients receive better care and can make more informed choices, providers are rewarded for achieving quality patient outcomes, purchasers are paying for what works, and businesses can invest in jobs and innovation.”
There have been mixed signals whether the Trump administration will move ahead with value-based initiatives. While some conservatives note that the vote for the Medicare Access and CHIP Reauthorization Act was overwhelming and supported by both parties, there are also statements from Price during his days as a Georgia congressman that mandatory value-based payment models were moving too quickly.
And last month HHS delayed the start date for a new cardiac bundled payment model and an expansion of a joint replacement model, after hospitals asked for more time. What’s more, there are signs Price may shift to a voluntary bundled payment model instead of a mandatary one.
A version of this story originally appears in the American Journal of Managed Care.